ARTICLE | Clinical News
Azilsartan medoxomil regulatory update
December 12, 2011 8:00 AM UTC
The European Commission approved Edarbi azilsartan medoxomil from Takeda to treat hypertension. Takeda plans to launch the once-daily angiotensin II type 1 (AT1) receptor blocker (ARB) across Europe ...